
### [NCIT:C39824](http://purl.obolibrary.org/obo/NCIT_C39824)
**Label:** Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

**Subclasses:** [NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements), [NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements), 

**Class expressions from DL-Learner:**

- Thing 55.94%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) 52.73%
- [NCIT:C36767](http://purl.obolibrary.org/obo/NCIT_C36767) (Abnormal Transitional Cell) 52.73%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 51.82%
- [NCIT:C60303](http://purl.obolibrary.org/obo/NCIT_C60303) (Malignant Spindle Transitional Cell) 50.91%
- [NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q) 50.91%
- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 50.91%
- [NCIT:C36681](http://purl.obolibrary.org/obo/NCIT_C36681) (MDM2 Gene Amplification) 50.91%
- [NCIT:C36679](http://purl.obolibrary.org/obo/NCIT_C36679) (HRAS Gene Amplification) 50.91%
- [NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification) 50.91%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 50.91%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 50.91%
- [NCIT:C36638](http://purl.obolibrary.org/obo/NCIT_C36638) (ERBB2 Gene Amplification) 50.91%
- [NCIT:C36636](http://purl.obolibrary.org/obo/NCIT_C36636) (Loss of Chromosome 9p) 50.91%
- [NCIT:C36599](http://purl.obolibrary.org/obo/NCIT_C36599) (Loss of Chromosome Y) 50.91%


